Journal of Inflammation Research, 2023 · DOI: https://doi.org/10.2147/JIR.S413264 · Published: June 13, 2023
Spinal cord injury (SCI) can lead to chronic neuropathic pain (NP), which significantly reduces the quality of life. This review discusses how non-coding RNAs (ncRNAs) play a role in regulating neuroinflammation after SCI, influencing the development of NP. Neuroinflammation, the immune system's response to injury after SCI, is linked to NP. Immune cells entering the spinal cord cause inflammation. Non-coding RNAs (ncRNAs) regulate gene expression, affect inflammation, and influence the prognosis of NP. Non-coding RNAs (ncRNAs), including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), are important in regulating gene expression in the central nervous system. These ncRNAs can act as sponges of RNAs or miRNAs, regulating the expression of NP-related molecules.
Non-coding RNAs can be potential targets for therapeutic interventions aimed at reducing neuroinflammation and neuropathic pain after spinal cord injury.
Development of effective and cell-specific delivery systems for ncRNAs is crucial to ensure targeted modulation of gene expression and minimize off-target effects.
Further research into the specific roles of ncRNAs can lead to personalized treatment strategies based on individual ncRNA expression profiles in SCI patients.